Escalante

📍 San Francisco, United States🗓 Founded 2024👥 3 employees💰 Last funded 2024
Biotechnology Research🌐 escalante.bio
Website LinkedIn
Escalante is dedicated to enabling the next generation of biological insights. Our platform unlocks scalable, functional, single-molecule proteomics by combining cutting-edge molecular biology, protein biochemistry, and artificial intelligence. We want to build AI models with a real understanding of how cells work. These models would transform biology and drug discovery, but require fundamentally new measurement technologies and datasets. To build these we rely on our people, our ambition, and our willingness to challenge the way science is done.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Escalante?
Escalante has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Escalante last raise funding?
The most recent investment in Escalante recorded on gritt.io was in 2024.
When was Escalante founded?
Escalante was founded in 2024.
What industry is Escalante in?
Escalante operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Escalante based?
Escalante is headquartered in San Francisco, United States.